Directory

>

Arthur Tzianabos

avatar

Arthur Tzianabos

Board Member | Stoke Therapeutics

Boston, Massachusetts, United States

View contact details (it's free)

Arthur Tzianabos

Summary

Arthur Tzianabos is a seasoned executive with extensive experience in the biopharmaceutical and biotechnology sectors. Currently serving as CEO of Lifordi Immunotherapeutics and a Venture Partner at 5AM Ventures, he has a proven track record in clinical development, drug discovery, and commercialization. With a strong academic background, including a Post Doctoral Fellowship in Immunology from Harvard Medical School, Arthur has held various leadership roles, including Chair of the Board at Homology Medicines and Stoke Therapeutics. His career reflects a commitment to advancing life sciences and regulatory compliance, and he is known for his cross-functional team leadership skills. Arthur's diverse roles in both startups and established firms demonstrate his adaptability and strategic vision in the rapidly evolving healthcare landscape. He is also involved in educational initiatives as a Board Member at the University of New Hampshire's College of Life Sciences and Agriculture. Outside of his professional endeavors, Arthur is passionate about fostering innovation in the life sciences industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Arthur Tzianabos

Work Experience

company logo

Board Member at

Q32 Bio Inc.

March 2024 - Present

company logo

Chief Executive Officer at

Lifordi Immunotherapeutics, Inc.

June 2023 - Present

company logo

Venture Partner at

5AM Ventures

September 2022 - Present

company logo

Board Of Directors at

Stoke Therapeutics

September 2018 - Present

company logo

Board Member at

UNH College of Life Sciences and Agriculture

March 2018 - Present

💼

Chair of The Board of Directors at

Q32 Bio Inc.

September 2022 - March 2024

company logo

Executive Committee Member at

Alliance for Regenerative Medicine

January 2019 - January 2024

company logo

Chair Of The Board Of Directors at

Akouos

August 2018 - December 2022

💼

President and CEO at

Q32 Bio Inc.

March 2016 - September 2022

company logo

President and CSO at

Ovascience

September 2013 - March 2016

company logo

Sr. Vice President and Head, Research and Early Development at

SHIRE LIMITED

March 2011 - September 2013

company logo

Vice President, Program Management at

SHIRE LIMITED

December 2008 - March 2011

company logo

Sr. Director, Discovery Research at

SHIRE LIMITED

October 2005 - November 2008

company logo

Associate Professor of Medicine at

Harvard University

January 1990 - January 2005

Logos provided by Logo.dev

Arthur Tzianabos

Education

Harvard Medical School, Post Doctoral Fellowship

January 1990 - January 1992

University of New Hampshire, Ph.D.

January 1985 - January 1989

Boston College, Bachelor Of Science - Bs

January 1981 - January 1985

Frequently Asked Questions about Arthur Tzianabos

What is Arthur Tzianabos email address?

Arthur Tzianabos's primary email address is ****************@unh.edu. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Arthur Tzianabos work for?

Arthur Tzianabos is a Board Member at Stoke Therapeutics, a company specializing in Commercial physical research.

Where Arthur Tzianabos graduated from?

Arthur Tzianabos holds a degree in Immunology from Harvard Medical School.

How can I directly contact Arthur Tzianabos?

To contact Arthur Tzianabos directly, you can use the email address ****************@unh.edu. Complete contact information is available upon registration with Muraena.

Who is Arthur Tzianabos?

Arthur Tzianabos is a seasoned executive with extensive experience in the biopharmaceutical and biotechnology sectors. Currently serving as CEO of Lifordi Immunotherapeutics and a Venture Partner at 5AM Ventures, he has a proven track record in clinical development, drug discovery, and commercialization. With a strong academic background, including a Post Doctoral Fellowship in Immunology from Harvard Medical School, Arthur has held various leadership roles, including Chair of the Board at Homology Medicines and Stoke Therapeutics. His career reflects a commitment to advancing life sciences and regulatory compliance, and he is known for his cross-functional team leadership skills. Arthur's diverse roles in both startups and established firms demonstrate his adaptability and strategic vision in the rapidly evolving healthcare landscape. He is also involved in educational initiatives as a Board Member at the University of New Hampshire's College of Life Sciences and Agriculture. Outside of his professional endeavors, Arthur is passionate about fostering innovation in the life sciences industry.

Arthur`s contact details

mail

****************@unh.edu

**********@stoketherapeutics.com

**********@5amventures.com

**********@homologymedicines.com

Colleagues

avatar
Anne Christiansen

Executive Director

Stephen Yu

VP Head of IT

avatar
Kimberly Parkerson

Senior Vice President, Head of Neurology Clinical Development

avatar
Samuel Manoranjan

Vice President of Quality

avatar
Shamim Ruff

Board Member

avatar
Meena

Svp, Dmpk & Bib (Bioanalysis, Immunogenicity And Biomarkers)

avatar
Katherine Pare Lefeber

Vice President, Strategy

avatar
Barbara Sutter

Vice President, Controller

avatar
Geno Clemenzi

Executive Director, Regulatory Affairs

avatar
Dawn Kalmar

Chief Communications Officer

View Contact details (it's free)
Request Profile Removal